Mark L. Ratner
It’s very much early days for researchers and drug developers trying to tap the potential of microRNAs (miRNAs), the small snippets of nucleotides once considered genomic junk. That miRNAs can profoundly affect protein production is becoming increasingly apparent: individual miRNAs might affect the expression of hundreds of genes, making them tempting targets for the development of small-molecule inhibitors
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Scrip for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?